Cargando…

The AMP-activated protein kinase beta 1 subunit modulates erythrocyte integrity

Failure to maintain a normal in vivo erythrocyte half-life results in the development of hemolytic anemia. Half-life is affected by numerous factors, including energy balance, electrolyte gradients, reactive oxygen species, and membrane plasticity. The heterotrimeric AMP-activated protein kinase (AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Cambridge, Emma L., McIntyre, Zoe, Clare, Simon, Arends, Mark J., Goulding, David, Isherwood, Christopher, Caetano, Susana S., Reviriego, Carmen Ballesteros, Swiatkowska, Agnieszka, Kane, Leanne, Harcourt, Katherine, Adams, David J., White, Jacqueline K., Speak, Anneliese O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823972/
https://www.ncbi.nlm.nih.gov/pubmed/27666489
http://dx.doi.org/10.1016/j.exphem.2016.09.006
Descripción
Sumario:Failure to maintain a normal in vivo erythrocyte half-life results in the development of hemolytic anemia. Half-life is affected by numerous factors, including energy balance, electrolyte gradients, reactive oxygen species, and membrane plasticity. The heterotrimeric AMP-activated protein kinase (AMPK) is an evolutionarily conserved serine/threonine kinase that acts as a critical regulator of cellular energy balance. Previous roles for the alpha 1 and gamma 1 subunits in the control of erythrocyte survival have been reported. In the work described here, we studied the role of the beta 1 subunit in erythrocytes and observed microcytic anemia with compensatory extramedullary hematopoiesis together with splenomegaly and increased osmotic resistance.